Notification of increase in shareholding

Current Report No. 24/2024

Preparation date: August 5, 2024

Subject: Notification of increase in shareholding

Legal basis: Legal basis: Article 70(1) of the Public Offering Act - acquisition or disposal of a significant block of shares

The Management Board of Captor Therapeutics S.A., based in Wrocław (the "Company"), announces that it has received a notification from Paweł Holstinghausen-Holsten, pursuant to Article 69 of the Act of 29 July 2005 on Public Offering, Conditions Governing the Introduction of Financial Instruments to Organised Trading and Public Companies, regarding a change in the shareholding in the total number of votes at the Company's General Meeting by Paweł Holstinghausen-Holsten, individually, and by his subsidiary, the "Holstinghausen-Holsten Family Foundation".

The content of the notification is attached to this report.

do niniejszego raportu.